Affinage

CLNS1A

Methylosome subunit pICln · UniProt P54105

Length
237 aa
Mass
26.2 kDa
Annotated
2026-06-09
28 papers in source corpus 11 papers cited in narrative 11 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/6 claims corpus-supported (83%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CLNS1A encodes ICln/pICln, a bifunctional protein that operates both as a chloride channel mediating regulatory volume decrease and as a dedicated substrate adaptor of the PRMT5 methylosome (PMID:10821842, PMID:34358446). Reconstitution in lipid bilayers and loss-of-function in fibroblasts and epithelial cells established its intrinsic ion channel activity and its essential role in cell volume regulation after swelling (PMID:10821842). As one of three PRMT5 adaptor proteins, CLNS1A engages PRMT5 through an evolutionarily conserved peptide motif that is necessary and sufficient for the interaction, and this interface recruits Sm proteins for symmetric arginine dimethylation; disrupting it impairs Sm spliceosome methylation, drives intron retention, and selectively compromises growth of MTAP-null tumor cells (PMID:34358446). By enabling Sm-protein methylation, CLNS1A is required for proper assembly and chromatin escape of mature mRNPs: its depletion accumulates SNRPB and SNRPD3 on chromatin, detains polyadenylated transcripts, upregulates detained introns, and the methylation-dependent block is rationalized by competition between the SMN Tudor domain and nucleic acids for methylated Sm tails (PMID:39149374, PMID:41086806). This PRMT5–splicing axis underlies the cellular consequences of CLNS1A loss—detained intron accumulation, cell cycle defects, and loss of viability dependent on Sm methylation (PMID:40687829)—and in CD4 T cells CLNS1A directs PRMT5-mediated H4R3me2s and expression of DNA repair, replication, and cell cycle genes, such that its deletion causes DNA damage, cell cycle arrest, and impaired T cell proliferation and effector function (PMID:40540585). In lung cancer cells CLNS1A additionally promotes drug efflux via its channel activity and activates the FAK-SRC-RAC1 pathway to enhance motility, while facilitating PRMT5-mediated RUVBL1 methylation to support DNA damage response signaling (PMID:40345428).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1996 Medium

    Establishing the genomic identity of CLNS1A defined it as a discrete intron-containing gene encoding a chloride channel and distinguished it from a homologous intronless locus, framing all later functional study.

    Evidence PCR strategies and FISH chromosomal mapping to 11q13.5-q14.1, with CLNS1B mapped to chromosome 6

    PMID:8975725 PMID:9524223

    Open questions at the time
    • Did not establish protein function beyond channel annotation
    • Relationship and expression of the CLNS1B locus not resolved
  2. 2000 High

    Demonstrating channel activity and a volume-regulation phenotype confirmed that the gene product is a functional ion channel rather than an annotation only.

    Evidence Promoter deletion/mutagenesis, ICln knockdown in NIH 3T3 fibroblasts and epithelial cells, and reconstitution in lipid bilayers

    PMID:10821842

    Open questions at the time
    • Did not connect channel function to any nuclear/RNA role
    • Conductance mechanism in native membranes not fully defined
  3. 2005 Low

    Testing CLNS1A in spermatozoa probed whether it serves as the volume-regulating chloride channel in this cell type, but its expression was inconsistent.

    Evidence Western blot, RT-PCR and flow-cytometric volume measurement in human sperm with channel blockers

    PMID:16033995

    Open questions at the time
    • CLNS1A detected in only 1 of 8 samples — finding largely negative
    • No functional perturbation of CLNS1A in sperm performed
  4. 2021 High

    Resolving the PRMT5–adaptor interface answered how CLNS1A recruits substrates to PRMT5 and revealed a shared modular binding motif, redefining CLNS1A as a methylosome adaptor with a cancer-relevant function.

    Evidence Conserved peptide-motif mapping, structural resolution of the PRMT5-adaptor interface, mutagenesis, spliceosome activity and growth assays in MTAP-null cells

    PMID:34358446

    Open questions at the time
    • Did not map the full sequence of substrate handoff during Sm core assembly
    • How adaptor competition (CLNS1A vs RIOK1 vs COPR5) is regulated unclear
  5. 2025 High

    Linking CLNS1A-dependent Sm methylation to mRNA chromatin escape showed why loss of methylation has transcriptome-wide consequences, connecting the adaptor function to nuclear RNA export.

    Evidence CLNS1A knockdown with spike-in fractionated transcriptomics/proteomics, isogenic SNRPB arginine mutants, and SMN Tudor-domain vs nucleic-acid competition assays (one peer-reviewed study and one preprint)

    PMID:39149374 PMID:41086806

    Open questions at the time
    • Causal chain from chromatin retention to specific export factors not fully resolved
    • Whether channel activity contributes to this nuclear function untested
  6. 2025 Medium

    Demonstrating that CLNS1A depletion drives detained intron accumulation, cell cycle defects and viability loss dependent on Sm methylation established the adaptor role as the basis of the PRMT5-splicing cancer vulnerability.

    Evidence CLNS1A depletion with detained intron splicing assays, viability and cell cycle analysis

    PMID:40687829

    Open questions at the time
    • Single-lab functional study
    • Which detained-intron targets drive the viability loss not pinpointed
  7. 2025 High

    T cell-specific knockout placed CLNS1A in adaptive immunity, showing its PRMT5 partnership controls histone methylation and a DNA repair/cell cycle gene program required for T cell proliferation and effector function.

    Evidence Forward genetic screen, T cell-specific Clns1a knockout mice, CLNS1A-PRMT5 Co-IP, histone methylation assays, EAE and IBD models

    PMID:40540585

    Open questions at the time
    • Direct targets of H4R3me2s in T cells not enumerated
    • Whether the channel function contributes to the T cell phenotype untested
  8. 2025 Medium

    Dissecting CLNS1A in lung cancer separated its channel-dependent drug efflux/motility role from its PRMT5-adaptor role in RUVBL1 methylation and DNA damage response.

    Evidence Overexpression/knockdown in lung cancer lines, channel-dead 3W mutant, drug accumulation/IC50 assays, pathway inhibition, xenografts

    PMID:40345428

    Open questions at the time
    • Mechanistic link between chloride transport and FAK-SRC-RAC1 activation unresolved
    • RUVBL1 methylation site and downstream DDR effectors not fully defined
  9. 2025 Low

    Computational modeling of the 6S intermediate proposed how phosphorylation regulates CLNS1A displacement during Sm core assembly, offering a mechanistic framework for substrate handoff.

    Evidence AlphaFold 3 modeling of full-length pICln with SmD1/D2/E/F/G integrated with prior biochemical data

    PMID:41503269

    Open questions at the time
    • Computational prediction only, not experimentally validated
    • ULK1-dependent phosphorylation of pICln C-terminus not demonstrated in cells
    • Displacement model untested biochemically

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CLNS1A's two activities — ion channel versus methylosome adaptor — are coordinated, and whether they share regulatory inputs, remains unresolved.
  • No structural or functional bridge between channel and adaptor states established
  • Regulatory signals selecting between the two functions unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 2 GO:0003723 RNA binding 1 GO:0060090 molecular adaptor activity 1 GO:0098772 molecular function regulator activity 1
Localization
GO:0005634 nucleus 3 GO:0005886 plasma membrane 2
Pathway
R-HSA-8953854 Metabolism of RNA 4 R-HSA-382551 Transport of small molecules 2 R-HSA-168256 Immune System 1 R-HSA-4839726 Chromatin organization 1
Complex memberships
6S Sm assembly intermediatePRMT5 methylosome

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1996 CLNS1A (ICln) was chromosomally mapped to chromosome 11q13.5-q14.1 by FISH, identifying it as an intron-containing gene (~19 kb) encoding a chloride channel essential for regulatory volume decrease. A second intronless pseudogene/locus (CLNS1B) was mapped to 6p12.1-6q13. PCR strategies and fluorescence in situ hybridization (FISH) Genomics Medium 8975725
1998 The CLNS1A gene at 11q13.5-q14.1 encodes ICln, a chloride channel fundamental for regulatory volume decrease; CLNS1B on chromosome 6p12 is an intronless gene 91.3% homologous to the CLNS1A coding region. Gene characterization, sequencing, and chromosomal localization Gene Medium 9524223
2000 The CLNS1A gene is driven by a constitutive promoter of 89 nucleotides that lacks a TATA box and initiates transcription at multiple sites; upstream sequence elements are required for efficient transcription. Knockdown of ICln in NIH 3T3 fibroblasts and epithelial cells demonstrated its crucial role in volume regulation after cytoplasmic swelling. Reconstitution of ICln in lipid bilayers confirmed its ion channel nature. Promoter deletion analysis, site-directed mutagenesis, ICln knockdown in cell lines, reconstitution in lipid bilayers The Journal of biological chemistry High 10821842
2005 CLNS1A (ICln) protein was detected in human spermatozoa by Western blotting in only 1 of 8 samples, and CLNS1A transcripts were found in some but not all sperm samples, indicating variable expression; CLCN3 was identified as the more consistent candidate Cl- channel for sperm volume regulation. Western blotting, RT-PCR, flow cytometry-based cell volume measurement with Cl- channel blockers Biology of reproduction Low 16033995
2021 CLNS1A is one of three substrate adaptor proteins for PRMT5 (along with RIOK1 and COPR5), all sharing an evolutionarily conserved peptide sequence (binding motif) that is necessary and sufficient for interaction with PRMT5. Structural resolution of the CLNS1A-PRMT5 interface showed that PRMT5 uses modular adaptor proteins with a common binding motif for substrate recruitment. Genetic disruption of this interface impairs Sm spliceosome methylation, causing intron retention, and impairs growth of MTAP-null tumor cells. Biochemical identification of conserved peptide motif, structural resolution of PRMT5-adaptor interface, genetic perturbation (mutagenesis), spliceosome activity assays, cell growth assays Molecular cell High 34358446
2024 Knockdown of CLNS1A (pICln), the PRMT5 adaptor that specifically enables Sm protein methylation, caused detention of mRNA (GRIPPs—genomically retained incompletely processed polyadenylated transcripts), accumulation of SNRPB and SNRPD3 on chromatin, and upregulation of detained introns. This demonstrated that CLNS1A-mediated PRMT5 activity on Sm proteins is required for mRNA chromatin escape and nuclear export. CLNS1A knockdown combined with fractionated transcriptomics (nascent and total RNA-seq), fractionated proteomics, isogenic SNRPB arginine mutants bioRxiv : the preprint server for biologypreprint Medium 39149374
2025 CLNS1A knockdown (pICln depletion) caused detention of polyadenylated mRNA and Sm proteins on chromatin, confirming that CLNS1A-mediated PRMT5 Sm-protein methylation is essential for mRNA processing and chromatin escape. Biochemical assays showed the SMN Tudor domain competes with nucleic acid binding of methylated Sm tails, providing a mechanistic link between arginine methylation and RNA-chromatin dynamics. CLNS1A knockdown, spike-in normalized fractionated transcriptomics, fractionated proteomics, isogenic SNRPB arginine mutants, biochemical competition assays (SMN Tudor domain vs. nucleic acids) Molecular cell High 41086806
2025 CLNS1A depletion was sufficient to induce detained intron (DI) upregulation, cell cycle defects, and loss of viability in a manner dependent on loss of Sm protein methylation. This established that CLNS1A specifically enables PRMT5-mediated Sm protein methylation, and that this function underlies the PRMT5-splicing axis central to cancer vulnerability. CLNS1A depletion, detained intron splicing assays, cell viability assays, cell cycle analysis iScience Medium 40687829
2025 In CD4 T cells, CLNS1A interacts with PRMT5 and regulates symmetric histone dimethylation (H4R3me2s) and expression of genes involved in DNA repair, replication, and cell cycle progression. Deletion of Clns1a in T cells caused DNA damage, cell cycle arrest, and impaired T cell proliferation and effector function, protecting mice from EAE and IBD. Forward genetic screen, T cell-specific Clns1a knockout mice, Co-immunoprecipitation (CLNS1A-PRMT5 interaction), histone methylation assays, EAE and IBD mouse models Science immunology High 40540585
2025 CLNS1A promotes drug efflux through its chloride channel activity and activates the FAK-SRC-RAC1 pathway to enhance cell motility and clonogenicity in lung cancer cells. It also facilitates PRMT5-mediated RUVBL1 methylation to support anti-apoptotic DNA damage response signaling. A chloride channel-defective 3W mutant (with steric hindrance at key bottleneck residues) impaired chloride ion transport, reducing drug resistance and migration. CLNS1A overexpression and knockdown in lung cancer cell lines, site-directed mutagenesis (3W mutant), drug accumulation assays, IC50 measurements, pathway inhibition, in vivo xenograft models Cancer letters Medium 40345428
2025 AlphaFold 3 modeling of the human 6S intermediate complex (full-length pICln/CLNS1A with SmD1/D2/E/F/G) combined with integration of prior biochemical data supports a model in which ULK1-dependent serine phosphorylation in the C-terminal alpha-helix of pICln abrogates its secondary structure, weakens interaction with SmG, and facilitates displacement of pICln by the SmD3/B dimer during spliceosomal Sm core assembly. AlphaFold 3 computational structural modeling integrated with published biochemical data Computational and structural biotechnology journal Low 41503269

Source papers

Stage 0 corpus · 28 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma. Cancer cell 179 28966034
1997 Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. Cytogenetics and cell genetics 132 9533029
2010 Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Human genetics 85 21079996
2021 Molecular basis for substrate recruitment to the PRMT5 methylosome. Molecular cell 77 34358446
2005 Chloride channels in physiological volume regulation of human spermatozoa. Biology of reproduction 50 16033995
2004 Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells. Biochimie 50 14987796
2007 Involvement of potassium and chloride channels and other transporters in volume regulation by spermatozoa. Current pharmaceutical design 24 18045171
2022 Cilia-Localized Counterregulatory Signals as Drivers of Renal Cystogenesis. Frontiers in molecular biosciences 18 35832738
2024 Genome-wide association analysis of fleece traits in Northwest Xizang white cashmere goat. Frontiers in veterinary science 11 38872797
2021 Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer. Cancers 11 34439272
2024 Identification of Novel Biomarkers for Alzheimer's Disease and Related Dementias Using Unbiased Plasma Proteomics. bioRxiv : the preprint server for biology 10 38260620
1996 Chromosomal localization of the genes (CLNS1A and CLNS1B) coding for the swelling-dependent chloride channel ICln. Genomics 9 8975725
2022 Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa. Frontiers in immunology 6 36479111
2019 Coix lacryma-jobi chymotrypsin inhibitor displays antifungal activity. Pesticide biochemistry and physiology 6 31519257
2025 Functional Foods for Cholesterol Management: A Review of the Mechanisms, Efficacy, and a Novel Cholesterol-Lowering Capacity Index. Nutrients 5 40871675
1998 Characterization of the human gene coding for the swelling-dependent chloride channel ICln at position 11q13.5-14.1 (CLNS1A) and further characterization of the chromosome 6 (CLNS1B) localization. Gene 5 9524223
2025 CLNS1A regulates genome stability and cell cycle progression to control CD4 T cell function and autoimmunity. Science immunology 4 40540585
2024 Productive mRNA Chromatin Escape is Promoted by PRMT5 Methylation of SNRPB. bioRxiv : the preprint server for biology 4 39149374
2000 The promoter for constitutive expression of the human ICln gene CLNS1A. The Journal of biological chemistry 3 10821842
2025 Productive mRNA chromatin escape is promoted by PRMT5 activity. Molecular cell 2 41086806
2025 Mechanistic insights into CLNS1A-mediated chemoresistance and tumor progression in non-small cell lung cancer. Cancer letters 1 40345428
2025 The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing. iScience 1 40687829
2019 Conditions of limited calcium influx (CLCI) inhibits IL2 induction and favors expression of anergy-related genes in TCR/CD3 and CD28 costimulated primary human T cells. Molecular immunology 1 31344552
2025 The ion transport, GPCR, and RTK toolkit expression in the human cerebrovascular endothelial cell line, hCMEC/D3: an Omics perspective. Frontiers in physiology 0 41488927
2025 Spliceosomal Sm core assembly: AlphaFold 3 predicted structure and phosphorylation-dependent regulation of the human 6S complex. Computational and structural biotechnology journal 0 41503269
2024 The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing. bioRxiv : the preprint server for biology 0 39763796
2015 [Screening and functional analysis of microRNA expression in HPV16-positive squamous carcinoma of the cervix 
in the Uygur of southern Xinjiang]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 0 26267680
2009 [Study on the differentially expressed genes of steroid-resistant and steroid-sensitive nephrotic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 0 20017314

Missed literature

Know a paper Affinage missed for CLNS1A? Flag it for the maintainers and the community.

No submissions yet.